Consistently, PIO, the agonist of PPARγ, successfully restored SREBP1 expression, cholesterol synthesis, and IFN-γ production in human tumor-infiltrating iNKT cells (Fig. 5h-j). The gene discussed is SREBF1; the disease is neoplasm.